nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AR—Spironolactone—dilated cardiomyopathy	0.813	1	CbGbCtD
Flutamide—Hepatic encephalopathy—Furosemide—dilated cardiomyopathy	0.0218	0.121	CcSEcCtD
Flutamide—Bullous eruption—Furosemide—dilated cardiomyopathy	0.008	0.0445	CcSEcCtD
Flutamide—Ulcer—Spironolactone—dilated cardiomyopathy	0.00614	0.0342	CcSEcCtD
Flutamide—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0052	0.0289	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0038	0.0211	CcSEcCtD
Flutamide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.0036	0.02	CcSEcCtD
Flutamide—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00336	0.0187	CcSEcCtD
Flutamide—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00325	0.0181	CcSEcCtD
Flutamide—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00315	0.0175	CcSEcCtD
Flutamide—Bladder pain—Furosemide—dilated cardiomyopathy	0.00286	0.0159	CcSEcCtD
Flutamide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.0027	0.015	CcSEcCtD
Flutamide—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00264	0.0147	CcSEcCtD
Flutamide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00254	0.0141	CcSEcCtD
Flutamide—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.0024	0.0134	CcSEcCtD
Flutamide—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00237	0.0132	CcSEcCtD
Flutamide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00236	0.0131	CcSEcCtD
Flutamide—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00232	0.0129	CcSEcCtD
Flutamide—Malaise—Spironolactone—dilated cardiomyopathy	0.00229	0.0128	CcSEcCtD
Flutamide—Cystitis—Lisinopril—dilated cardiomyopathy	0.00229	0.0127	CcSEcCtD
Flutamide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00227	0.0127	CcSEcCtD
Flutamide—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00224	0.0125	CcSEcCtD
Flutamide—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00214	0.0119	CcSEcCtD
Flutamide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00214	0.0119	CcSEcCtD
Flutamide—Confusional state—Spironolactone—dilated cardiomyopathy	0.00209	0.0116	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00207	0.0115	CcSEcCtD
Flutamide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00203	0.0113	CcSEcCtD
Flutamide—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00198	0.011	CcSEcCtD
Flutamide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00191	0.0106	CcSEcCtD
Flutamide—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00186	0.0103	CcSEcCtD
Flutamide—Somnolence—Spironolactone—dilated cardiomyopathy	0.00184	0.0103	CcSEcCtD
Flutamide—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00181	0.0101	CcSEcCtD
Flutamide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00179	0.00996	CcSEcCtD
Flutamide—Drowsiness—Furosemide—dilated cardiomyopathy	0.00177	0.00984	CcSEcCtD
Flutamide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00171	0.00951	CcSEcCtD
Flutamide—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00171	0.00951	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00155	0.00863	CcSEcCtD
Flutamide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00147	0.00816	CcSEcCtD
Flutamide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00142	0.0079	CcSEcCtD
Flutamide—Erythema—Furosemide—dilated cardiomyopathy	0.00138	0.00769	CcSEcCtD
Flutamide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00137	0.00763	CcSEcCtD
Flutamide—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00137	0.00763	CcSEcCtD
Flutamide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00136	0.00756	CcSEcCtD
Flutamide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00134	0.00747	CcSEcCtD
Flutamide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00132	0.00734	CcSEcCtD
Flutamide—Rash—Spironolactone—dilated cardiomyopathy	0.00131	0.00728	CcSEcCtD
Flutamide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00131	0.00727	CcSEcCtD
Flutamide—Headache—Spironolactone—dilated cardiomyopathy	0.0013	0.00723	CcSEcCtD
Flutamide—Jaundice—Lisinopril—dilated cardiomyopathy	0.00129	0.0072	CcSEcCtD
Flutamide—Anaemia—Furosemide—dilated cardiomyopathy	0.00128	0.00711	CcSEcCtD
Flutamide—Haematuria—Lisinopril—dilated cardiomyopathy	0.00127	0.00704	CcSEcCtD
Flutamide—Leukopenia—Furosemide—dilated cardiomyopathy	0.00124	0.00689	CcSEcCtD
Flutamide—Nausea—Spironolactone—dilated cardiomyopathy	0.00123	0.00685	CcSEcCtD
Flutamide—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00119	0.00663	CcSEcCtD
Flutamide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00117	0.00653	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00117	0.0065	CcSEcCtD
Flutamide—Confusional state—Furosemide—dilated cardiomyopathy	0.00114	0.00633	CcSEcCtD
Flutamide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.0011	0.00615	CcSEcCtD
Flutamide—Skin disorder—Furosemide—dilated cardiomyopathy	0.0011	0.0061	CcSEcCtD
Flutamide—Anorexia—Furosemide—dilated cardiomyopathy	0.00108	0.00598	CcSEcCtD
Flutamide—Erythema—Lisinopril—dilated cardiomyopathy	0.00104	0.00577	CcSEcCtD
Flutamide—Tension—Lisinopril—dilated cardiomyopathy	0.00102	0.00566	CcSEcCtD
Flutamide—Nervousness—Lisinopril—dilated cardiomyopathy	0.00101	0.00561	CcSEcCtD
Flutamide—Somnolence—Furosemide—dilated cardiomyopathy	0.001	0.00558	CcSEcCtD
Flutamide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000981	0.00546	CcSEcCtD
Flutamide—Fatigue—Furosemide—dilated cardiomyopathy	0.000973	0.00541	CcSEcCtD
Flutamide—Constipation—Furosemide—dilated cardiomyopathy	0.000965	0.00537	CcSEcCtD
Flutamide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000962	0.00536	CcSEcCtD
Flutamide—Anaemia—Lisinopril—dilated cardiomyopathy	0.000959	0.00533	CcSEcCtD
Flutamide—Malaise—Lisinopril—dilated cardiomyopathy	0.000935	0.00521	CcSEcCtD
Flutamide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00093	0.00517	CcSEcCtD
Flutamide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000928	0.00517	CcSEcCtD
Flutamide—Anxiety—Lisinopril—dilated cardiomyopathy	0.00088	0.0049	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000877	0.00488	CcSEcCtD
Flutamide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000872	0.00486	CcSEcCtD
Flutamide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000853	0.00475	CcSEcCtD
Flutamide—Oedema—Lisinopril—dilated cardiomyopathy	0.000846	0.00471	CcSEcCtD
Flutamide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000829	0.00461	CcSEcCtD
Flutamide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000822	0.00458	CcSEcCtD
Flutamide—Asthenia—Furosemide—dilated cardiomyopathy	0.000809	0.0045	CcSEcCtD
Flutamide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000807	0.00449	CcSEcCtD
Flutamide—Pruritus—Furosemide—dilated cardiomyopathy	0.000798	0.00444	CcSEcCtD
Flutamide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000772	0.0043	CcSEcCtD
Flutamide—Insomnia—Lisinopril—dilated cardiomyopathy	0.000766	0.00426	CcSEcCtD
Flutamide—Somnolence—Lisinopril—dilated cardiomyopathy	0.000752	0.00419	CcSEcCtD
Flutamide—Dizziness—Furosemide—dilated cardiomyopathy	0.000746	0.00415	CcSEcCtD
Flutamide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000736	0.0041	CcSEcCtD
Flutamide—Fatigue—Lisinopril—dilated cardiomyopathy	0.00073	0.00406	CcSEcCtD
Flutamide—Constipation—Lisinopril—dilated cardiomyopathy	0.000724	0.00403	CcSEcCtD
Flutamide—Vomiting—Furosemide—dilated cardiomyopathy	0.000717	0.00399	CcSEcCtD
Flutamide—Rash—Furosemide—dilated cardiomyopathy	0.000711	0.00396	CcSEcCtD
Flutamide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000711	0.00395	CcSEcCtD
Flutamide—Headache—Furosemide—dilated cardiomyopathy	0.000707	0.00393	CcSEcCtD
Flutamide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000697	0.00388	CcSEcCtD
Flutamide—Nausea—Furosemide—dilated cardiomyopathy	0.00067	0.00373	CcSEcCtD
Flutamide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000607	0.00338	CcSEcCtD
Flutamide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000599	0.00333	CcSEcCtD
Flutamide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000579	0.00322	CcSEcCtD
Flutamide—Dizziness—Lisinopril—dilated cardiomyopathy	0.00056	0.00312	CcSEcCtD
Flutamide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000538	0.003	CcSEcCtD
Flutamide—Rash—Lisinopril—dilated cardiomyopathy	0.000534	0.00297	CcSEcCtD
Flutamide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000533	0.00297	CcSEcCtD
Flutamide—Headache—Lisinopril—dilated cardiomyopathy	0.00053	0.00295	CcSEcCtD
Flutamide—AHR—cardiac ventricle—dilated cardiomyopathy	0.000521	0.17	CbGeAlD
Flutamide—Nausea—Lisinopril—dilated cardiomyopathy	0.000503	0.0028	CcSEcCtD
Flutamide—AHR—myocardium—dilated cardiomyopathy	0.00049	0.16	CbGeAlD
Flutamide—AHR—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.000362	0.0841	CbGpPWpGaD
Flutamide—AHR—heart—dilated cardiomyopathy	0.000342	0.112	CbGeAlD
Flutamide—AHR—cardiac atrium—dilated cardiomyopathy	0.000292	0.0955	CbGeAlD
Flutamide—AR—cardiac ventricle—dilated cardiomyopathy	0.000257	0.0839	CbGeAlD
Flutamide—AR—myocardium—dilated cardiomyopathy	0.000242	0.0789	CbGeAlD
Flutamide—AHR—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000201	0.0467	CbGpPWpGaD
Flutamide—AR—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000193	0.0448	CbGpPWpGaD
Flutamide—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.000192	0.0627	CbGeAlD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000181	0.042	CbGpPWpGaD
Flutamide—CYP1B1—heart—dilated cardiomyopathy	0.000178	0.0582	CbGeAlD
Flutamide—AR—heart—dilated cardiomyopathy	0.000169	0.0551	CbGeAlD
Flutamide—AR—cardiac atrium—dilated cardiomyopathy	0.000144	0.0471	CbGeAlD
Flutamide—AHR—Adipogenesis—LMNA—dilated cardiomyopathy	0.000144	0.0334	CbGpPWpGaD
Flutamide—CYP1A1—heart—dilated cardiomyopathy	0.000126	0.0411	CbGeAlD
Flutamide—AHR—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000126	0.0292	CbGpPWpGaD
Flutamide—CYP1B1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000122	0.0284	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000114	0.0264	CbGpPWpGaD
Flutamide—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000108	0.0352	CbGeAlD
Flutamide—AR—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	8.79e-05	0.0204	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	8.61e-05	0.02	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	8.61e-05	0.02	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—FAS—dilated cardiomyopathy	8.41e-05	0.0195	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	8.2e-05	0.019	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	8.2e-05	0.019	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	8.11e-05	0.0188	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—AGT—dilated cardiomyopathy	7.88e-05	0.0183	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	7.68e-05	0.0178	CbGpPWpGaD
Flutamide—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	7.52e-05	0.0175	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	7.52e-05	0.0175	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	7.32e-05	0.017	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.71e-05	0.0156	CbGpPWpGaD
Flutamide—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	6.15e-05	0.0143	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—FAS—dilated cardiomyopathy	5.94e-05	0.0138	CbGpPWpGaD
Flutamide—AR—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	5.83e-05	0.0135	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	5.63e-05	0.0131	CbGpPWpGaD
Flutamide—CYP1B1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.41e-05	0.0126	CbGpPWpGaD
Flutamide—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	5.26e-05	0.0122	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	5.18e-05	0.012	CbGpPWpGaD
Flutamide—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	5.02e-05	0.0117	CbGpPWpGaD
Flutamide—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	4.79e-05	0.0111	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	4.64e-05	0.0108	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	3.78e-05	0.00878	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—TNF—dilated cardiomyopathy	3.57e-05	0.0083	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	3.52e-05	0.00818	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	3.47e-05	0.00806	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.35e-05	0.00778	CbGpPWpGaD
Flutamide—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	3.33e-05	0.00774	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	3.33e-05	0.00774	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	3.33e-05	0.00773	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	3.17e-05	0.00735	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.15e-05	0.00732	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	2.74e-05	0.00638	CbGpPWpGaD
Flutamide—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	2.73e-05	0.00634	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	2.48e-05	0.00575	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	2.41e-05	0.00561	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.41e-05	0.00561	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.3e-05	0.00534	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	2.3e-05	0.00534	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	2.21e-05	0.00514	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.17e-05	0.00504	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	2.17e-05	0.00504	CbGpPWpGaD
Flutamide—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	2.13e-05	0.00494	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	2.09e-05	0.00486	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.09e-05	0.00486	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.06e-05	0.00479	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.05e-05	0.00477	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.94e-05	0.0045	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	1.73e-05	0.00401	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	1.72e-05	0.00399	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	1.69e-05	0.00393	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.69e-05	0.00392	CbGpPWpGaD
Flutamide—AR—Gene Expression—NR3C2—dilated cardiomyopathy	1.6e-05	0.00373	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.59e-05	0.00369	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	1.56e-05	0.00361	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	1.52e-05	0.00354	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	1.49e-05	0.00347	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	1.49e-05	0.00345	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	1.49e-05	0.00345	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	1.42e-05	0.00329	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	1.42e-05	0.00329	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	1.4e-05	0.00326	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	1.38e-05	0.00321	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.36e-05	0.00316	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.32e-05	0.00306	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	1.27e-05	0.00295	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.24e-05	0.00287	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	1.17e-05	0.00271	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	1.13e-05	0.00262	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	1.05e-05	0.00244	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.04e-05	0.00243	CbGpPWpGaD
Flutamide—AR—Gene Expression—NPPA—dilated cardiomyopathy	1.01e-05	0.00234	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	9.72e-06	0.00226	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	9.48e-06	0.0022	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	9.48e-06	0.0022	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	9.33e-06	0.00217	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	9.19e-06	0.00213	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	9.14e-06	0.00212	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	9.03e-06	0.0021	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	9.03e-06	0.0021	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.89e-06	0.00206	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	8.64e-06	0.00201	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	8.27e-06	0.00192	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	7.81e-06	0.00181	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.74e-06	0.0018	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.53e-06	0.00175	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	7.52e-06	0.00175	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	7.07e-06	0.00164	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.78e-06	0.00158	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	6.39e-06	0.00148	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	5.86e-06	0.00136	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	5.51e-06	0.00128	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	4.98e-06	0.00116	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.76e-06	0.00111	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.64e-06	0.00108	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.52e-06	0.00105	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.25e-06	0.000987	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.18e-06	0.00097	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.9e-06	0.000906	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.84e-06	0.000893	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.8e-06	0.000882	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	3.45e-06	0.0008	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.42e-06	0.000794	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	3.36e-06	0.000779	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.04e-06	0.000706	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	3.02e-06	0.000702	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.96e-06	0.000687	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.66e-06	0.000619	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	2.25e-06	0.000522	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	2.19e-06	0.000508	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	2.12e-06	0.000493	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	2.07e-06	0.00048	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.97e-06	0.000457	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	1.86e-06	0.000432	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.74e-06	0.000403	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.69e-06	0.000393	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.52e-06	0.000354	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.35e-06	0.000314	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.32e-06	0.000306	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.19e-06	0.000276	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.04e-06	0.000243	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.02e-06	0.000236	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	9.15e-07	0.000213	CbGpPWpGaD
